Literature DB >> 36175555

Organ dysfunction, thrombotic events and malignancies in patients with idiopathic multicentric castleman disease: a population-level US health claims analysis.

Sudipto Mukherjee1, Karan Kanhai2, David Kauffman3, Rabecka Martin4, Jeremy S Paige3, Anirvan Ghosh3, Hannah Kannan3, Francis Shupo2, David C Fajgenbaum5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 36175555     DOI： 10.1038/s41375-022-01690-2

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  7 in total

1.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

Review 2.  Overview of Castleman disease.

Authors:  Angela Dispenzieri; David C Fajgenbaum
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

3.  Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease.

Authors:  Sheila K Pierson; Aaron J Stonestrom; Dustin Shilling; Jason Ruth; Christopher S Nabel; Amrit Singh; Yue Ren; Katie Stone; Hongzhe Li; Frits van Rhee; David C Fajgenbaum
Journal:  Am J Hematol       Date:  2018-05-16       Impact factor: 10.047

Review 4.  Truven Health Analytics MarketScan Databases for Clinical Research in Colon and Rectal Surgery.

Authors:  Audrey S Kulaylat; Eric W Schaefer; Evangelos Messaris; Christopher S Hollenbeak
Journal:  Clin Colon Rectal Surg       Date:  2019-01-08

5.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

6.  ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder.

Authors:  Sheila K Pierson; Johnson S Khor; Jasira Ziglar; Amy Liu; Katherine Floess; Erin NaPier; Alexander M Gorzewski; Mark-Avery Tamakloe; Victoria Powers; Faizaan Akhter; Eric Haljasmaa; Raj Jayanthan; Arthur Rubenstein; Mileva Repasky; Kojo Elenitoba-Johnson; Jason Ruth; Bette Jacobs; Matthew Streetly; Linus Angenendt; Jose Luis Patier; Simone Ferrero; Pier Luigi Zinzani; Louis Terriou; Corey Casper; Elaine Jaffe; Christian Hoffmann; Eric Oksenhendler; Alexander Fosså; Gordan Srkalovic; Amy Chadburn; Thomas S Uldrick; Megan Lim; Frits van Rhee; David C Fajgenbaum
Journal:  Cell Rep Med       Date:  2020-12-22

Review 7.  Idiopathic multicentric Castleman's disease: a systematic literature review.

Authors:  Amy Y Liu; Christopher S Nabel; Brian S Finkelman; Jason R Ruth; Razelle Kurzrock; Frits van Rhee; Vera P Krymskaya; Dermot Kelleher; Arthur H Rubenstein; David C Fajgenbaum
Journal:  Lancet Haematol       Date:  2016-03-17       Impact factor: 18.959
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.